+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vifor Pharma - logo

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

From
Anemia And Other Blood Disorder Drugs Global Market Report 2024 - Product Thumbnail Image

Anemia And Other Blood Disorder Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Beta-thalassemia - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-thalassemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Chemotherapy Induced Anemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Chemotherapy Induced Anemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 72 Pages
  • Global
From
From
Omega 3 Prescription Drugs Global Market Report 2024 - Product Thumbnail Image

Omega 3 Prescription Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Chronic Kidney Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Kidney Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anemia - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Anemia - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
From
From
From
Vaccine Sales Market Report 2023-2033 - Product Thumbnail Image

Vaccine Sales Market Report 2023-2033

  • Report
  • June 2023
  • 364 Pages
  • Global
From
From
Thalassemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Thalassemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 215 Pages
  • Global
From
Loading Indicator